ReviewPeerJ2026
From sequencing to intelligence: how AI is transforming metagenomics.
Review in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial communities are critical in advancing human health. Metagenomics is a technique that analyzes these communities and allows for investigating their composition and functions. Metagenomic shotgun sequencing enables to capture all of the genetic material in environmental samples, such as water, soil, or the human gut. Despite this advantage, one of the main challenges of this technique is the assembling and interpreting of its data, as it produces many short, fragmented reads. Though long-read technologies may change this in the future, artificial intelligence (AI), machine learning (ML) and data science (DS) offer a powerful solution now, enabling scientists to efficiently process and analyze these large and complex datasets. This review explores the latest advancements in AI and ML applications across the metagenomic pipeline. First, it examines the impact of deep learning (DL) on next-generation sequencing, particularly for long-read technologies. Then, it discusses how ML is automating and improving quality control processes, as well as the use of AI applications in metagenome-assembled genome (MAG) assembly, with a focus on contig binning. Finally, this article looks at how AI and ML can improve predictive modeling for phenotype prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.